ArticleCancer chemotherapy and pharmacology2012

Phase I dose escalation study of KOS-1584, a novel epothilone, in patients with advanced solid tumors.

Elaine T Lam et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.